Reverse Takotsubo Cardiomyopathy After Casirivimab-Imdevimab Therapy in a Patient with COVID-19: A Case Report

22 September 2022 : Case report USA

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease

Salman Salehin^1ABDEFG*, Deaa Abu Jazar^1AEF, Syed Mustajab Hasan^2EFG, Hussein Al-Sudani

^3EF, Muhammad W. Raja^2EFG

DOI: 10.12659/AJCR.936886

Am J Case Rep 2022; 23:e936886

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. CXR demonstrating unremarkable cardiomediastinal silhouette. Lungs expanded and clear. No pleural effusion seen.

Back to the Article